Shawn McCarthy traded his vice president role at AngioDynamics Inc. (NSDQ:ANGO) for the corner office at Tryton Medical Inc., assuming the president and CEO spot at the Durham, N.C.-based stent maker.
McCarthy was senior vice president and general manager of AngioDynamics’ vascular and oncology surgery business units. AngioDynamics reported $12.3 million in net income on $216 million in sales last year. Tryton is a much smaller operation, posting $1.7 million to the top line in 2010.
Before AngioDynamics, McCarthy served as worldwide vice president of marketing for Cordis Corp., a division of Johnson & Johnson (NYSE:JNJ).
- Cardio Vascular Medical Device Corp. files for changes in leadership
Cardio Vascular Medical Device Corp. (OTC:CVSL) shuffled its executive deck, according to regulatory filings. David Hostelley leaves his role as sole officer and director to take over as CFO, Thomas DiCicco becomes president & director and Michael DiCicco becomes vice president and director. Thomas DiCicco also purchased 62.8 percent of the company’s restricted common shares.
- Neogen gets a new board member
William Boehm will join the board of directors at Neogen Corp. (NSDQ:NEOG) in place of Robert Book, who resigned in March after serving 21 years on the board. Boehm recently retired as senior vice president of Kroger Co. and is former senior economist for the President’s Council of Economic Advisors.
- Olympus Corp. of the Americas president & CEO retires
The American arm of Japan-based Olympus Corp. announcement the retirement of president & CEO Mark Gumz. Current vice president & CFO Michael Woodford will be promoted to president.
- Olympus Biotech names new president
In a second Olympus Corp. seat-change, the company’s biotech division appointed new president Oliver Burckhardt, who will join the board of directors and lead the company’s North American business and focus on the regenerative medicine market
- Lewin Group appoints new director of Center for Comparative Effectiveness Research
The Lewin Group announced that Dr. Paul Wallace joined as senior vice president and director of its Center for Comparative Effectiveness Research. Wallace was medical director for health and productivity management programs at Kaiser Permanente.
- PLC Medical names new vice president of clinical affairs
PLC Medical Systems Inc. appointed Susan Papalia as the new vice president of clinical affairs, where she will be responsible for overseeing and leading the U.S. clinical study of the company’s RenalGuard device.
- Mindray names new general counsel
Mindray Medical International Ltd. (NYSE:MR) appointed Fannie Lin Fan as general counsel of the company. Fan succeeds Tim Fitzpatrick, who will step down in June.